Vaccination

Study boosts support for single-dose HPV vaccine regimen

A randomized controlled trial of 2,275 women in Kenya showed that a single dose of the human papillomavirus (HPV) vaccine was highly effective. The current standard for women is a three-dose regimen.

Oncology & Cancer

HPV vaccination may be cutting cervical cancer rates

(HealthDay)—The recent decrease in the incidence of cervical cancers, particularly in young women, may be associated with human papillomavirus (HPV) vaccination approval, according to a study published online March 16 in ...

page 16 from 40